Prenetics Global Ltd (PRE) - Future Profit

Prenetics Global Ltd (PRE) - corporate logo

Prenetics Global (PRE) is transforming its business toward precision medicine and early oncology diagnostics. Growth is driven by the Asian genomics market and the integration of CircleDNA into insurance. Strategic alliances with clinics enhance personalized care, which is supported by the revenue projection chart. The value of 0.01 represents the current future profit metric, allowing investors to assess the real-time valuation of the company's expected earnings.

Prenetics Global Limited (PRE): Company Profit Forecast from 04/28/2023 to 03/16/2026

PRE (Prenetics Global Ltd): analytical breakdowns and indicator data

- price and consensus price forecast:
- market capitalization indicators:
Summary company analytics:PRE, Prenetics Global Limited
Core merchandise of Prenetics Global Limited

This indicator aggregates consolidated analyst net income forecasts, allowing investors to assess the asset's fundamental value through discounted cash flow analysis. By analyzing the trend of future business profitability, one can identify the risks of inflated expectations, which are particularly critical for Prenetics Global (PRE) amid price wars and the expansion of tech behemoths into the home diagnostics sector.